Overview

Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The objective is to investigate the bioequivalence of 2 dose strengths of 40 mg and 120 mg BI 201335 NA soft gelatine capsules.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim